Ignite Creation Date:
2025-12-24 @ 11:38 PM
Ignite Modification Date:
2026-02-02 @ 6:35 AM
Study NCT ID:
NCT01118351
Status:
TERMINATED
Last Update Posted:
2019-05-01
First Post:
2010-05-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sunitinib Malate in Treating Patients With Recurrent Transitional Cell Bladder Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization: